Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 44.85% | 49.30% | -- |
| Total Depreciation and Amortization | -- | -- | -25.47% | 186.22% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -100.00% | -- |
| Change in Net Operating Assets | -- | -- | 70.06% | 78.73% | -- |
| Cash from Operations | -- | -- | 60.47% | 54.72% | -305.04% |
| Capital Expenditure | -- | -- | 91.04% | -813.64% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 91.04% | -813.64% | -120.56% |
| Total Debt Issued | -- | -- | 153.85% | -29.74% | -- |
| Total Debt Repaid | -- | -- | 98.66% | -76,245.45% | -- |
| Issuance of Common Stock | -- | -- | -- | -1.94% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -14,727.68% | -- |
| Cash from Financing | -- | -- | 158.46% | -112.98% | 1,344.77% |
| Foreign Exchange rate Adjustments | -- | -- | -267.41% | 24.43% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 89.15% | -190.24% | 24,673.53% |